NCT00080496View on ClinicalTrials.gov

Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia

PHASE3CompletedINTERVENTIONAL

Enrollment

430

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

December 31, 2006

Conditions

Bacterial Pneumonia

Interventions

DRUG

Tigecycline

DRUG

Imipenem

DRUG

Cilastatin

Trial Locations (29)

19102

Philadelphia

19140

Philadelphia

21201

Baltimore

27536

Henderson

29605

Greenville

30076

Roswell

30342

Atlanta

30909

Augusta

32601

Gainesville

32806

Orlando

33744

Bay Pines

34428

Crystal River

43071

Zanesville

45219

Cincinnati

60610

Chicago

62769

Springfield

62781

Springfield

65212

Columbia

70112

New Orleans

71103

Shreveport

85006

Phoenix

85013

Phoenix

91950

National City

94553

Martinez

95350

Modesto

95355

Modesto

85251-6403

Scottsdale

85260-6709

Scottsdale

68198-5300

Omaha

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00080496 - Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia | Biotech Hunter | Biotech Hunter